Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Ruffolo

Showing results (201-210 of 230) with videos related to

Pageof 23
Sort By:
British Journal of Pharmacology|April 11, 1992
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogsJ P Hieble, A J Nichols, T A Fredrickson, et al.
Pharmacology|July 1, 1997
Ser165 of transmembrane helix IV is not involved in the interaction of catecholamines with the alpha-2a-adrenoceptorA Hehr, J P Hieble, Y O Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872A Bril, B Gout, M Bonhomme, et al.
Journal of Medicinal Chemistry|July 1, 1984
The 3,4-catechol derivative of propranolol, a minor dihydroxylated metaboliteW L Nelson, M J Bartels, P J Bednarski, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Electrophysiological effect of BRL-32872, a novel antiarrhythmic agent with potassium and calcium channel blocking properties, in guinea pig cardiac isolated preparationsA Bril, J F Faivre, M C Forest, et al.
British Journal of Pharmacology|June 1, 1993
Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failureD P Brooks, B G Short, M J Cyronak, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepinesR N Daly, A C Sulpizio, B Levitt, et al.
European Journal of Pharmacology|January 14, 1994
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidantT L Yue, P J Mckenna, P G Lysko, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbitsX L Ma, T L Yue, B L Lopez, et al.
Cardiovascular Research|May 11, 1992
Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranololA Bril, M Slivjak, M J DiMartino, et al.
Pageof 23

Showing results (201-210 of 230) with videos related to

Sort By:
Pageof 23
British Journal of Pharmacology|April 11, 1992
Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogsJ P Hieble, A J Nichols, T A Fredrickson, et al.
Pharmacology|July 1, 1997
Ser165 of transmembrane helix IV is not involved in the interaction of catecholamines with the alpha-2a-adrenoceptorA Hehr, J P Hieble, Y O Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872A Bril, B Gout, M Bonhomme, et al.
Journal of Medicinal Chemistry|July 1, 1984
The 3,4-catechol derivative of propranolol, a minor dihydroxylated metaboliteW L Nelson, M J Bartels, P J Bednarski, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Electrophysiological effect of BRL-32872, a novel antiarrhythmic agent with potassium and calcium channel blocking properties, in guinea pig cardiac isolated preparationsA Bril, J F Faivre, M C Forest, et al.
British Journal of Pharmacology|June 1, 1993
Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failureD P Brooks, B G Short, M J Cyronak, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepinesR N Daly, A C Sulpizio, B Levitt, et al.
European Journal of Pharmacology|January 14, 1994
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidantT L Yue, P J Mckenna, P G Lysko, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbitsX L Ma, T L Yue, B L Lopez, et al.
Cardiovascular Research|May 11, 1992
Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranololA Bril, M Slivjak, M J DiMartino, et al.
Pageof 23